208 related articles for article (PubMed ID: 19389744)
1. Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Albavera-Hernández C; Rodríguez JM; Idrovo AJ
Clin Rehabil; 2009 May; 23(5):394-407. PubMed ID: 19389744
[TBL] [Abstract][Full Text] [Related]
2. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Dubinsky RM
Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
[No Abstract] [Full Text] [Related]
3. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review.
Koog YH; Min BI
Clin Rehabil; 2010 Aug; 24(8):685-700. PubMed ID: 20554641
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A in children. New indication for limb spasticity.
Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
[No Abstract] [Full Text] [Related]
8. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
9. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
[TBL] [Abstract][Full Text] [Related]
10. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
11. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin and spasticity.
Davis EC; Barnes MP
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):143-7. PubMed ID: 10896682
[No Abstract] [Full Text] [Related]
13. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
Mathevon L; Declemy A; Laffont I; Perennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
[TBL] [Abstract][Full Text] [Related]
14. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
15. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
Kim H; Kolaski K
NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
[TBL] [Abstract][Full Text] [Related]
16. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
17. Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review.
Fonseca PR; Calhes Franco de Moura R; Galli M; Santos Oliveira C
Eur J Phys Rehabil Med; 2018 Oct; 54(5):757-765. PubMed ID: 29185676
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
[TBL] [Abstract][Full Text] [Related]
19. Use of botulinum toxin A in children with cerebral palsy.
Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
[TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
